Erin Cook
Boston
Education
Sc.D., cancer epidemiology, Harvard T.H. Chan School of Public Health; M.P.H., health policy, Dartmouth College; B.A., French, Washington University in St. Louis
Summary of Experience
Dr. Cook is an experienced epidemiology and health outcomes researcher, with a particular focus on real-world data assessment. She has conducted multiple studies in a variety of therapeutic areas, including dementia, oncology, cardiovascular disease, nutrition, and chronic inflammatory disorders. Dr. Cook’s research has covered a wide range of methodologies, including health economics (e.g., policy analyses, cost-effectiveness analysis, budget impact models); systematic literature review and indirect comparisons; trial analysis; patient surveys; and retrospective database analyses (e.g., claims and electronic medical record research). She has presented her work at numerous conferences and been published in peer-reviewed scientific medical journals.
Selected Publishing
-
Association of Serum Calcium and Phosphate with Incident Cardiovascular Disease in Patients with Hypoparathyroidism
American Journal of Cardiology, 2023
2023Kaul S, Ayodele O, Chen K, Cook EE, Swallow E, Rejnmark L, Gosmanova EO
-
Budget Impact Analysis of REBYOTA™ (Fecal Microbiota, Live-Jslm [FMBL]) for Preventing Recurrent Clostridioides Difficile Infection in the US
Advances in Therapy, 2023
2023Lodise T, Guo A, Yang M, Cook EE, Song W, Yang D, Wang Q, Zhao A, Bochan M
-
Cost-Effectiveness Analysis of REBYOTA™ (Fecal Microbiota, Live-Jslm [FMBL]) Versus Standard of Care for the Prevention of Recurrent Clostridioides Difficile Infection in the USA
Advances in Therapy, 2023
2023Lodise T, Guo A, Yang M, Cook EE, Song W, Yang D, Wang Q, Zhao A, Bochan M
-
Real-World Modifications of Renin-Angiotensin-Aldosterone System Inhibitors in Patients with Hyperkalemia Initiating Sodium Zirconium Cyclosilicate Therapy: The Optimize I Study
Advances in Therapy, 2023
2023Agiro A, Amin AN, Cook EE, Mu F, Chen J, Desai P, Oluwatosin Y, Pollack CV
-
Real-World Outcomes Associated with Vonoprazan-Based Versus Proton Pump Inhibitor-Based Therapy for Helicobacter Pylori Infection in Japan
Therapeutic Advances in Gastroenterology, 2023
2023Howden CW, Cook EE, Swallow E, Yang K, Guo H, Pelletier C, Jacob R, Sugano K
-
Impact on Hospitalizations of Long-Term Versus Short-Term Therapy with Sodium Zirconium Cyclosilicate During Routine Outpatient Care of Patients with Hyperkalemia: The Recognize I Study
Expert Review of Pharmacoeconomics and Outcomes Research, 2023
2023Pollack CV, Agiro A, Mu F, Cook EE, Wirtz EL, Young JA, Betts KA, Brahmbhatt YG
-
Impact of benralizumab on asthma exacerbation-related medical healthcare resource utilization and medical costs: results from the ZEPHYR 2 study
Journal of Medical Economics, 2023
2023Chung Y, Maselli DJ, Mu F, Cook EE, Yang D, Young JA, Betts KA, Genofre E, Carstens D
-
Real-world effectiveness of benralizumab: results from the ZEPHYR 1 Study
Annals of Allergy, Asthma & Immunology, 2022
2022Chung Y, Katial R, Mu F, Cook E, Young J, Yang D, Betts K, Carstens D
-
The Economic Burden of Eosinophilic Gastritis and Eosinophilic Enteritis in the United States
Advances in Therapy, 2022
2022Woolley M, Cook EE, Mu F, Betts KA, Billmyer E, Yim E, Chen J, Wu EQ
-
Real-World Management of Hyperkalemia in the Emergency Department: An Electronic Medical Record Analysis
Advances in Therapy, 2022
2022Davis J, Israni R, Betts KA, Mu F, Cook EE, Anzalone D, Szerlip H, Yin L, Uwaifo GI, Wu EQ
-
Association of Calcium and Phosphate Levels with Incident Chronic Kidney Disease in Patients with Hypoparathyroidism: A Retrospective Case-Control Study
International Journal of Endocrinology, 2022
2022Gosmanova EO, Ayodele O, Chen K, Cook EE, Mu F, Young JA, Rejnmark L
-
Inpatient Management and Post-Discharge Outcomes of Hyperkalemia
Hospital Practice, 2021
2021Davis J, Israni R, Mu F, Cook E, Szerlip H, Uwaifo G, Fonseca V, Betts K
-
Prevalence of Metabolic Acidosis Among Patients with Chronic Kidney Disease and Hyperkalemia
Advances in Therapy, 2021
2021Cook EE, Davis J, Israni R, Mu F, Betts KA, Anzalone D, Yin L, Szerlip H, Uwaifo GI, Fonseca V, Wu EQ
-
Primary Hyperoxaluria Type 1 Disease Manifestations and Healthcare Utilization: A Multi-Country, Online, Chart Review Study
Frontiers in Medicine, 2021
2021Wang X, Danese D, Brown T, Baldwin J, Sajeev G, Cook EE, Wang Y, Xu C, Hongbo Yang H, Moritz ML
News
-
March 2, 2023
-
April 5, 2022
-
July 20, 2021